This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

FDA Approves Competing Lung Disease Drugs From Roche and Boehringer

10/15/14 - 04:07 PM EDT

U.S. patients suffering from idiopathic pulmonary fibrosis finally gain access to Esbriet, approved for use in Europe since early 2011.

READ FULL POST

Gilead Sciences Falls Amid Worries Over Hep-C Drug Price

10/14/14 - 10:53 AM EDT

It's one thing for small-cap biotech stocks to trade horribly, but healthcare investors take notice when shares of Gilead Sciences GILD take a turn south.

READ FULL POST

Blame Arrowhead Management Entirely for Today's Epic Collapse

10/08/14 - 03:52 PM EDT

CEOs of early stage biotech companies like Arrowhead cannot deliver nasty surprises to Wall Street, yet some inexplicable reason, Anzalone totally botched the job.

READ FULL POST

The Disgusting Reaction to Ebola Patient's Death by Tekmira, Chimerix Traders

10/08/14 - 11:33 AM EDT

Tekmira shares surge after Thomas Duncan's death announced.

READ FULL POST

Arrowhead Research Sinks on Disappointing Hepatitis B Drug Data

10/08/14 - 10:38 AM EDT

In an ongoing phase II study, ARC-520 dosed at 2 mg/kg induced a 0.3 log reduction in HBsAG, a measure of the presence of hepatitis B virus in the body.

READ FULL POST

It's True, Small-Cap Biotech Stocks Are Acting Badly These Days

10/07/14 - 11:39 AM EDT

For the past three months, small-cap biotech stocks have been underperforming the broader market.

READ FULL POST

Shkreli's Inability to Focus, Immaturity Cost Him Retrophin CEO Job

09/30/14 - 05:53 PM EDT

Martin is super smart and will be a great asset somewhere, but he is not a CEO. I wish him the best.

READ FULL POST

Why J&J Expands Antiviral Franchise but Doesn't Buy Achillion, Novavax

09/30/14 - 09:49 AM EDT

What are the motivations behind significant takeovers, like J&J's takeover of Alios Biopharma? And why have companies like Achillion and Novavax been passed over?

READ FULL POST

Clovis Shares Higher on Improved Outlook for Lung Cancer Drug

09/29/14 - 12:17 PM EDT

Clovis Oncology shares are higher Monday because AstraZeneca, its direct competitor to develop a new, genetically targeted lung cancer drug, slipped this weekend.

READ FULL POST

Gilead Sciences' Next-Generation HIV Drug Hits the Mark

09/24/14 - 10:30 AM EDT

TAF is an improved version of Gilead's stalwart but patent challenged HIV drug Viread.

READ FULL POST

Markets

DOW 18,010.68 -115.44 -0.64%
S&P 500 2,107.39 -13.40 -0.63%
NASDAQ 5,070.0260 -27.95 -0.55%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs